Key Highlights
- Marvell Technology’s CEO Matthew Murphy executed a sale of 7,500 shares valued at $1.77 million on August 17, pursuant to a pre-established 10b5-1 plan.
- The semiconductor stock has surged over 160% since the start of the year, currently hovering near $234.33.
- Fiscal year 2027 Q2 results are scheduled for August 27, with consensus estimates calling for $0.93 earnings per share and $2.71 billion in revenue.
- UBS analysts elevated their price objective to $340, while Goldman Sachs increased theirs to $195 with a Neutral stance.
- Consensus analyst projections point to a price target of $272.73, suggesting approximately 16% potential appreciation.
On August 17, 2026, Matthew Murphy, Chief Executive Officer of Marvell Technology, divested 7,500 shares of MRVL stock, generating proceeds of roughly $1.77 million. The transaction occurred at an average weighted price of $236.08 per share, with execution prices spanning from $230.44 to $239.66.
This transaction was executed through a Rule 10b5-1 trading arrangement that Murphy established in December 2025. Such plans allow executives to sell shares on a predetermined schedule, meaning the transaction doesn’t inherently signal a shift in management’s perspective regarding company prospects.
Following this divestiture, Murphy maintains direct ownership of 783,186 Marvell shares, representing substantial continued investment in the company’s future.
Shares of MRVL are currently changing hands around $234.33, representing a remarkable surge of more than 160% since January. Looking at the trailing twelve-month period, the stock has appreciated approximately 206%.
Marvell Technology, Inc., MRVL
While the CEO’s transaction occurred under a scheduled plan, overall insider selling has been substantial. Data from TipRanks indicates that company insiders have collectively sold $632.3 million in MRVL shares during the previous three-month period, resulting in a Negative Insider Confidence Signal designation for the stock.
Analyst Expectations for Upcoming Quarterly Report
Marvell is scheduled to unveil its second quarter fiscal 2027 financial performance on August 27. The Street consensus anticipates adjusted earnings of $0.93 per share, marking an increase from $0.67 reported in the comparable year-ago period. Revenue projections stand at $2.71 billion, representing year-over-year expansion of 35%.
Management’s own guidance pointed toward approximately $2.7 billion in quarterly revenue. CEO Murphy has highlighted “exceptional AI-related bookings” the company is experiencing and indicated momentum is anticipated to strengthen throughout the current fiscal year.
Gross profit margins are forecast to settle within the 52.1% to 53.1% range for the period.
Wall Street Divided on Valuation Metrics
James Schneider from Goldman Sachs maintained his Neutral recommendation while elevating his price objective from $180 to $195. Schneider noted that Marvell stands “well positioned” to capitalize on expanding optical connectivity demand and custom silicon deployments, with increased cloud infrastructure spending expected to bolster the data-center segment.
Timothy Arcuri at UBS demonstrated greater optimism, reaffirming his Buy rating and raising his target price significantly from $230 to $340. His bullish stance centers on expanding opportunities in Compute Express Link (CXL) technology.
Conversely, Erste Group moved to a more cautious position, downgrading the stock from Buy to Hold due to valuation considerations.
The semiconductor sector, including Marvell, received a tailwind after Amazon disclosed $25 billion in annual revenue from its artificial intelligence and semiconductor operations, boosting multiple chip-related equities.
According to TipRanks data, the consensus analyst price target stands at $272.73, implying roughly 16% upside potential from present trading levels. The stock holds a Strong Buy consensus rating, supported by 23 Buy recommendations and five Hold ratings.
Analysis from InvestingPro suggests the stock is trading above its Fair Value calculation, though the platform also highlights an attractive PEG ratio of 0.13 and awards Marvell a “GREAT” financial health rating.


